IRCT20210917052506N1招募中2 期
Evaluation of the therapeutic efficacy and safety of dalfampridine on patients with Devic syndrome: A triple-blind randomized clinical trial study
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 65 years（—）
- 性别
- All
入选标准
- •Age between 16 to 65 years
- •T25FW-based gait disorder: Test between 5 and 60 seconds
- •Definitive diagnosis of Devic disease based on wingerchuc criteria
- •No other neurological or psychological disease
- •No relapse during the three months prior to enrollment
排除标准
- 未提供
研究者
相似试验
已完成
4 期
Evaluation of the therapeutic efficacy and safety of pyronaridine-artesunate for the treatment of uncomplicated falciparum malaria in areas of artemisinin-resistant falciparum malaria in Viet NamACTRN12618001274268Ministry of Health, Viet Nam153
尚未招募
4 期
a clinical trial to compare efficacy of the analgesic activity of inj. Bupivacaine vs inj. Ropivacaine given at transverse abdominis block and also compare the safety parameters also.CTRI/2017/08/009249Department of Anaesthesiology
进行中（未招募）
1 期
Evaluation the safety and efficacy of the treatment of scars and cutis laxa syndrome with the use of autologous (fresh and stored) stem cells isolated from adipose tissue within the project: 'The therapeutic potential of mesenchymal stem cells tested in clinical trials and in vitro - a justification for characterized cells storage'.EUCTR2016-004110-10-PLMedical University of Warsaw100
进行中（未招募）
1 期
Evaluation of treatment effectiveness and safety of somatic cell based therapy for urinary incontinence in patients after radical prostatectomy.urinary incontinenceMedDRA version: 20.0Level: LLTClassification code: 10021643Term: Incontinence urinary Class: 10038359CTIS2023-509812-27-00icolaus Copernicus University45
招募中
不适用
Safety evaluation and therapeutic effect analysis of knee hyperthermia with resonant cavity applicatorJPRN-UMIN000033721nternational University of Health and Welfare20